SXC Health Solutions announces services agreement with MAXIMUS BC Health in province of British Columbia

    - Company plans to deliver in excess of $1.6 million in services
    associated with upgrade to B.C. PharmaNet System -

    MILTON, ON, March 4 /CNW/ - SXC Health Solutions Corp. ("SXC") (TSX: SXC,
NASDAQ:   SXCI), a leading provider of pharmacy benefits management ("PBM")
services and healthcare IT solutions to the healthcare benefits management
industry, announces that it has entered into a two-year $1.6 million services
agreement with MAXIMUS BC Health Inc. ("MAXIMUS BC"), a subsidiary of MAXIMUS,
Inc. (NYSE:   MMS). All dollar amounts in U.S. dollars.
    The agreement calls for the delivery of both professional and software
development services by SXC to support the PharmaNet upgrade project. SXC's
solution provides government and commercial clients with access to proven
electronic medication history management and state-of-the-art HL7 Version 3
claims processing technology.
    "We are very pleased to extend our relationship with our valued partner
MAXIMUS BC," said Gordon Glenn, Chairman and CEO of SXC. "This agreement
ensures that MAXIMUS BC will have ongoing access to SXC resources for the
consulting and software enhancement services that will be needed as part of
our joint PharmaNet upgrade project."
    "The current PharmaNet application is a leading edge solution for the
provision of patient medication histories, drug use evaluation, claims
adjudication and payment reconciliation," said Duff Lang, President, MAXIMUS
BC Health Inc. "We look forward to expanding our partnership with SXC to
launch the next generation of the DIS as part of the Ministry of Health
eHealth Electronic Health Record initiative to create a safer and more
efficient health care system. This effort will broaden the quality service we
already deliver to the pharmaceutical and medical communities in British
    SXC's software is the core processing engine for health record
transactions in the PharmaNet System. The upgraded solution will include
implementation of the pan-Canadian Electronic Drug ("CeRx") Messaging Standard
established under the leadership of Canada Health Infoway Inc. Based in HL7
Version 3, CeRx ensures that the software is transferable and interoperable in
other Canadian jurisdictions. SXC's DIS software applications have now been
licensed in two provinces - British Columbia and the province of Newfoundland
and Labrador. Funding for this major upgrade to British Columbia's PharmaNet
system comes from the Province and Canada Health Infoway, a federal,
non-profit organization with the mandate to accelerate the development of
electronic health information systems across Canada.

    About SXC Health Solutions Corp.

    SXC Health Solutions Corp. (formerly Systems Xcellence, Inc.) is a
leading provider of pharmacy benefits management (PBM) services and healthcare
IT solutions to the healthcare benefits management industry. The Company's
product offerings and solutions combine a wide range of software applications,
application service provider (ASP) processing services and professional
services, designed for many of the largest organizations in the pharmaceutical
supply chain, such as Federal, provincial, and, state and local governments,
pharmacy benefit managers, managed care organizations, retail pharmacy chains
and other healthcare intermediaries. SXC is based in Lisle, Illinois with
locations in; Scottsdale, Arizona; Warminster, Pennsylvania; Alpharetta,
Georgia; Milton, Ontario and Victoria, British Columbia. For more information
please visit

    About MAXIMUS, Inc.

    MAXIMUS is a leading provider of program management, consulting and
information technology primarily to government clients. The Company has more
than 6,000 employees located in more than 220 offices in the United States,
Canada and Australia. MAXIMUS is included in the Russell 2000 Index and the
S&P SmallCap 600 Index.

    Forward-Looking Statements

    Certain statements included herein, including those that express
management's expectations or estimates of our future performance, constitute
"forward-looking statements" within the meaning of applicable securities laws.
Forward-looking statements are necessarily based upon a number of estimates
and assumptions that, while considered reasonable by management at this time,
are inherently subject to significant business, economic and competitive
uncertainties and contingencies. We caution that such forward-looking
statements involve known and unknown risks, uncertainties and other risks that
may cause our actual financial results, performance, or achievements to be
materially different from our estimated future results, performance or
achievements expressed or implied by those forward-looking statements.
Numerous factors could cause actual results to differ materially from those in
the forward-looking statements, including without limitation, our ability to
achieve increased market acceptance for our product offerings and penetrate
new markets; consolidation in the healthcare industry; the existence of
undetected errors or similar problems in our software products; our ability to
identify and complete acquisitions, manage our growth and integrate
acquisitions; our ability to compete successfully; potential liability for the
use of incorrect or incomplete data; the length of the sales cycle for our
healthcare software solutions; interruption of our operations due to outside
sources; our dependence on key customers; maintaining our intellectual
property rights and litigation involving intellectual property rights; our
ability to obtain, use or successfully integrate third-party licensed
technology; compliance with existing laws, regulations and industry
initiatives and future change in laws or regulations in the healthcare
industry; breach of our security by third parties; our dependence on the
expertise of our key personnel; our access to sufficient capital to fund our
future requirements; and potential write-offs of goodwill or other intangible
assets. This list is not exhaustive of the factors that may affect any of our
forward-looking statements. Other factors that should be considered are
discussed from time to time in SXC's filings with the Canadian Securities
Administrators, including the risks and uncertainties discussed under Item 8,
Risk Factors in our Annual Information Form dated March 23, 2007, which is
available at Investors are cautioned not to put undue reliance
on forward-looking statements. All subsequent written and oral forward-looking
statements attributable to SXC or persons acting on our behalf are expressly
qualified in their entirety by this notice. We disclaim any intent or
obligation to update publicly these forward-looking statements, whether as a
result of new information, future events or otherwise. Risks and uncertainties
about our business are more fully discussed in our Annual Information Form.
    Certain of the assumptions made in preparing forward-looking information
and management's expectations include: maintenance of our existing customers
and contracts, our ability to market our products successfully to anticipated
customers, the impact of increasing competition, the growth of prescription
drug utilization rates at predicted levels, the retention of our key
personnel, our customers continuing to process transactions at historical
levels, that our systems will not be interrupted for any significant period of
time, that our products will perform free of major errors, our ability to
obtain financing on acceptable terms and that there will be no significant
changes in the regulation of our business.

    %SEDAR: 00001439E

For further information:

For further information: Jeff Park, Chief Financial Officer, SXC Health
Solutions, Tel: (630) 577-3206,; Dave Mason, Investor
Relations, The Equicom Group Inc., (416) 815-0700 ext. 237,; Susan Noonan, Investor Relations - U.S., The SAN
Group, LLC, (212) 966-3650,

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890